Stasia Ogden is the Vice President, Intellectual Property for Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on next-generation T cell immunotherapy.  Prior to joining Tmunity, Stasia served as Vice President, Global Patent Litigation Governance for GlaxoSmithKline.  She has over two decades of intellectual property and business experience at Baxter, Becton, Dickinson and Company, Motorola, Inc., Monsanto Company and Johnson & Johnson.  Prior to going in-house, Stasia worked for the intellectual property law firms of Finnegan, Henderson, Farabow, Garrett & Dunner and Cushman, Darby & Cushman.  Stasia received a B.A. in Biochemistry from Northwestern University, completed graduate course work in Immunology at the Johns Hopkins University School of Medicine, received her J.D. from Georgetown University Law Center, and her M.B.A. from the University of Missouri, St. Louis.